Improvements in Health-Related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries,1 and accounts for approximately one-third of new leukemia cases in the United States each year.2 It is seen mainly in older adults, with an average age at diagnosis of 70 years.3
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Alexey V. Danilov, Habte A. Yimer, Michael A. Boxer, John M. Burke, Sunil Babu, Jia Li, Yong Mun, Peter C. Trask, Anthony S. Masaquel, Jeff P. Sharman Tags: Original article Source Type: research
More News: Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia | Lymphoma | Myeloma | Study | Treanda | USA Health